US4703008A
(en)
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
NZ210501A
(en)
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
KR850004274A
(ko)
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
US5856298A
(en)
|
1989-10-13 |
1999-01-05 |
Amgen Inc. |
Erythropoietin isoforms
|
KR100263845B1
(ko)
|
1989-10-13 |
2000-08-16 |
스튜어트 엘.왓트 |
에리트로포이에틴 동형체와 그의 제조방법 및 그를 포함하는제약학적 조성물
|
US5149792A
(en)
|
1989-12-19 |
1992-09-22 |
Amgen Inc. |
Platelet-derived growth factor B chain analogs
|
US5272064A
(en)
|
1989-12-19 |
1993-12-21 |
Amgen Inc. |
DNA molecules encoding platelet-derived growth factor B chain analogs and method for expression thereof
|
ZA946122B
(en)
|
1993-08-17 |
1995-03-20 |
Amgen Inc |
Erythropoietin analogs
|
US5830851A
(en)
|
1993-11-19 |
1998-11-03 |
Affymax Technologies N.V. |
Methods of administering peptides that bind to the erythropoietin receptor
|
US5773569A
(en)
|
1993-11-19 |
1998-06-30 |
Affymax Technologies N.V. |
Compounds and peptides that bind to the erythropoietin receptor
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
DE69534530T2
(de)
|
1994-08-12 |
2006-07-06 |
Immunomedics, Inc. |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
MX9707021A
(es)
|
1995-03-23 |
1997-11-29 |
Immunex Corp |
Receptor de il-7.
|
US5686292A
(en)
|
1995-06-02 |
1997-11-11 |
Genentech, Inc. |
Hepatocyte growth factor receptor antagonist antibodies and uses thereof
|
US5767078A
(en)
|
1995-06-07 |
1998-06-16 |
Johnson; Dana L. |
Agonist peptide dimers
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
DE69838552T2
(de)
|
1997-07-14 |
2008-05-21 |
Bolder Biotechnology, Inc., Louisville |
Derivate des wachstumshormons und verwandte proteine
|
US6753165B1
(en)
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
PT986644E
(pt)
|
1997-07-23 |
2007-01-31 |
Roche Diagnostics Gmbh |
Preparação de eritropoietina por activação genética endógena com promotores virais
|
US6030086A
(en)
|
1998-03-02 |
2000-02-29 |
Becton, Dickinson And Company |
Flash tube reflector with arc guide
|
US6200289B1
(en)
*
|
1998-04-10 |
2001-03-13 |
Milestone Scientific, Inc. |
Pressure/force computer controlled drug delivery system and the like
|
US6310078B1
(en)
|
1998-04-20 |
2001-10-30 |
Ortho-Mcneil Pharmaceutical, Inc. |
Substituted amino acids as erythropoietin mimetics
|
ATE339507T1
(de)
|
1998-06-15 |
2006-10-15 |
Gtc Biotherapeutics Inc |
Erythropoietin-analog-menschliches serum-albumin fusionsprotein
|
US20050181482A1
(en)
|
2004-02-12 |
2005-08-18 |
Meade Harry M. |
Method for the production of an erythropoietin analog-human IgG fusion proteins in transgenic mammal milk
|
KR20010075661A
(ko)
|
1998-10-23 |
2001-08-09 |
스티븐 엠. 오드레 |
빈혈 예방 및 치료 방법과 이를 위한 조성물
|
ES2388341T3
(es)
|
1998-10-23 |
2012-10-11 |
Kirin-Amgen Inc. |
Péptidos miméticos de trombopoyetina diméricos que se unen al receptor MPL y que tienen actividad trombopoyética
|
DK2261335T3
(en)
|
1998-11-27 |
2017-09-18 |
Ucb Pharma Sa |
Compositions and Methods for Increasing Bone Mineralization
|
EP1006184A1
(en)
|
1998-12-03 |
2000-06-07 |
F. Hoffmann-La Roche Ag |
IGF-1 receptor interacting proteins (IIPs) genes coding therefor and uses thereof
|
EP1169352A4
(en)
|
1999-04-14 |
2005-05-04 |
Smithkline Beecham Corp |
ANTIBODY AGAINST THE ERYTHROPOIETIN RECEPTOR
|
US7297680B2
(en)
|
1999-04-15 |
2007-11-20 |
Crucell Holland B.V. |
Compositions of erythropoietin isoforms comprising Lewis-X structures and high sialic acid content
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
AU1099601A
(en)
|
1999-10-22 |
2001-05-08 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules derived from rat brain and programmed cell death models
|
JP2003514552A
(ja)
|
1999-11-12 |
2003-04-22 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
改善された性質を有するエリトロポエチンの形態
|
US20050202538A1
(en)
|
1999-11-12 |
2005-09-15 |
Merck Patent Gmbh |
Fc-erythropoietin fusion protein with improved pharmacokinetics
|
AUPQ599700A0
(en)
|
2000-03-03 |
2000-03-23 |
Super Internet Site System Pty Ltd |
On-line geographical directory
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
EP2292651A1
(en)
|
2000-04-21 |
2011-03-09 |
Amgen Inc. |
Methods and compositions for the prevention and treatment of anemia
|
US6756480B2
(en)
|
2000-04-27 |
2004-06-29 |
Amgen Inc. |
Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
|
US7078376B1
(en)
|
2000-08-11 |
2006-07-18 |
Baxter Healthcare S.A. |
Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
|
GB0020058D0
(en)
*
|
2000-08-16 |
2000-10-04 |
Smiths Industries Plc |
Syringe pumps
|
AU2001278905B2
(en)
|
2000-09-08 |
2004-12-16 |
Gryphon Therapeutics, Inc. |
Synthetic erythropoiesis stimulating proteins
|
US7271689B1
(en)
|
2000-11-22 |
2007-09-18 |
Fonar Corporation |
Magnet structure
|
WO2002049673A2
(en)
|
2000-12-20 |
2002-06-27 |
F. Hoffmann-La Roche Ag |
Conjugates of erythropoietin (pep) with polyethylene glycol (peg)
|
EE05724B1
(et)
|
2001-01-05 |
2014-10-15 |
Pfizer Inc. |
Antikehad insuliinitaolise kasvufaktori I retseptorile
|
AU2002319142B2
(en)
|
2001-04-04 |
2008-02-21 |
Genodyssee |
New polynucleotides and polypeptides of the erythropoietin gene
|
SI1385882T1
(sl)
|
2001-05-11 |
2008-04-30 |
Amgen Inc |
Peptidi in sorodne molekule, ki se vežejo na tall-1
|
DE60235989D1
(de)
|
2001-06-26 |
2010-05-27 |
Amgen Fremont Inc |
Antikörper gegen opgl
|
US6900292B2
(en)
|
2001-08-17 |
2005-05-31 |
Lee-Hwei K. Sun |
Fc fusion proteins of human erythropoietin with increased biological activities
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
PT1425389E
(pt)
|
2001-08-23 |
2012-02-07 |
Genmab As |
Anticorpos humanos específicos para interleucina 15 (il-15)
|
US6930086B2
(en)
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
US7138370B2
(en)
|
2001-10-11 |
2006-11-21 |
Amgen Inc. |
Specific binding agents of human angiopoietin-2
|
AU2002351746A1
(en)
|
2001-12-21 |
2003-07-15 |
Maxygen Aps |
Erythropoietin conjugates
|
US7241444B2
(en)
|
2002-01-18 |
2007-07-10 |
Pierre Fabre Medicament |
Anti-IGF-IR antibodies and uses thereof
|
MXPA04006980A
(es)
|
2002-01-18 |
2004-11-10 |
Pf Medicament |
Anticuerpos novedosos anti-receptor del factor de crecimiento i tipo insulina, y usos de los mismos.
|
EP1470232A1
(en)
|
2002-01-31 |
2004-10-27 |
Oxford Biomedica (UK) Limited |
Physiologically regulated erythropoietin-expressing vector for the treatment of anaemia
|
GB0202252D0
(en)
|
2002-01-31 |
2002-03-20 |
Oxford Biomedica Ltd |
Anemia
|
SE520340C2
(sv)
*
|
2002-03-14 |
2003-06-24 |
Billy Nilson |
Ambulatorisk membranpump
|
SI1492878T1
(sl)
|
2002-03-26 |
2007-12-31 |
Lek Pharmaceutical And Chemical Co. D.D. |
Postopek za pripravo Ĺľelenega profila gliko-izoform eritropoietina
|
CN101565708B
(zh)
|
2002-03-29 |
2011-09-21 |
组合化学工业株式会社 |
编码乙酰乳酸合酶的基因
|
EP1572079A4
(en)
|
2002-03-29 |
2006-09-06 |
Centocor Inc |
MAMMAL-CDR MIMETIC BODIES, COMPOSITIONS, PROCESSES AND APPLICATION PURPOSES
|
CA2485365A1
(en)
|
2002-05-13 |
2003-11-20 |
Modigenetech Ltd. |
Ctp-extended erythropoietin
|
IL165256A0
(en)
|
2002-05-24 |
2005-12-18 |
Schering Corp |
Neutralizing human anti-igfr antibody
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
US8034904B2
(en)
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
JP2006504406A
(ja)
|
2002-06-28 |
2006-02-09 |
セントカー・インコーポレーテツド |
哺乳動物のch1欠失ミメティボディ、組成物、方法および使用
|
MXPA05000202A
(es)
|
2002-06-28 |
2005-09-30 |
Johnson & Johnson |
Cuerpos mimeicos ch1-deletados de epo de mimetica de mamifero.
|
WO2004009627A1
(en)
|
2002-07-19 |
2004-01-29 |
Cangene Corporation |
Pegylated erythropoietic compounds
|
AU2003254950A1
(en)
|
2002-08-26 |
2004-03-11 |
Kirin Beer Kabushiki Kaisha |
Peptides and drugs containing the same
|
CN104178491B
(zh)
|
2002-09-06 |
2018-07-03 |
安姆根有限公司 |
治疗性人抗-il-1r1单克隆抗体
|
WO2005025606A1
(en)
|
2003-09-09 |
2005-03-24 |
Warren Pharmaceuticals, Inc. |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
WO2004024776A1
(en)
|
2002-09-11 |
2004-03-25 |
Fresenius Kabi Deutschland Gmbh |
Method of producing hydroxyalkyl starch derivatives
|
US6919426B2
(en)
|
2002-09-19 |
2005-07-19 |
Amgen Inc. |
Peptides and related molecules that modulate nerve growth factor activity
|
TWI320716B
(en)
|
2002-10-14 |
2010-02-21 |
Abbott Lab |
Erythropoietin receptor binding antibodies
|
US7396913B2
(en)
|
2002-10-14 |
2008-07-08 |
Abbott Laboratories |
Erythropoietin receptor binding antibodies
|
US20040071694A1
(en)
|
2002-10-14 |
2004-04-15 |
Devries Peter J. |
Erythropoietin receptor binding antibodies
|
WO2004034988A2
(en)
|
2002-10-16 |
2004-04-29 |
Amgen Inc. |
Human anti-ifn-ϝ neutralizing antibodies as selective ifn-ϝ pathway inhibitors
|
US20040091961A1
(en)
|
2002-11-08 |
2004-05-13 |
Evans Glen A. |
Enhanced variants of erythropoietin and methods of use
|
PT1581649E
(pt)
|
2002-12-20 |
2011-04-13 |
Amgen Inc |
Agentes de ligação que inibem a miostatina
|
WO2004083248A1
(en)
|
2003-03-14 |
2004-09-30 |
Pharmacia Corporation |
Antibodies to igf-i receptor for the treatment of cancers
|
ATE549359T1
(de)
|
2003-04-02 |
2012-03-15 |
Hoffmann La Roche |
Antikörper gegen den insulinähnlichen wachstumsfaktor i-rezeptor und deren verwendungen
|
US7220410B2
(en)
|
2003-04-18 |
2007-05-22 |
Galaxy Biotech, Llc |
Monoclonal antibodies to hepatocyte growth factor
|
CA2524305C
(en)
|
2003-05-01 |
2015-12-08 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
TWI353991B
(en)
|
2003-05-06 |
2011-12-11 |
Syntonix Pharmaceuticals Inc |
Immunoglobulin chimeric monomer-dimer hybrids
|
EA010099B1
(ru)
|
2003-05-12 |
2008-06-30 |
Афимакс, Инк. |
Пептиды, которые связываются с рецептором к эритропоэтину, и способы их применения
|
BRPI0411160A
(pt)
|
2003-05-12 |
2006-07-11 |
Affymax Inc |
novos compostos modificados com poli(glicol etilênico) e usos dos mesmos
|
MXPA05012316A
(es)
|
2003-05-12 |
2006-04-18 |
Affymax Inc |
Peptidos novedosos que se unen al receptor de la eritropoyetina.
|
US7074755B2
(en)
|
2003-05-17 |
2006-07-11 |
Centocor, Inc. |
Erythropoietin conjugate compounds with extended half-lives
|
EP1641481A4
(en)
|
2003-05-30 |
2008-10-15 |
Centocor Inc |
TRAINING OF NEW ERYTHROPOIETIN CONJUGATES USING TRANSGLUTAMINASE
|
US20050037390A1
(en)
|
2003-06-04 |
2005-02-17 |
Irm Llc, A Delaware Limited Liability Company |
Methods and compositions for modulating erythropoietin expression
|
BRPI0411212A
(pt)
*
|
2003-06-09 |
2006-07-18 |
Nipro Diabetes Systems Inc |
sistema de liberação de lìquido
|
AR046071A1
(es)
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
NZ599196A
(en)
|
2003-07-15 |
2014-01-31 |
Amgen Inc |
Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
|
WO2005017107A2
(en)
|
2003-07-18 |
2005-02-24 |
Amgen Inc. |
Specific binding agents to hepatocyte growth factor
|
US20050019914A1
(en)
|
2003-07-24 |
2005-01-27 |
Aventis Pharma Deutschland Gmbh |
Perfusion process for producing erythropoietin
|
US20070275871A1
(en)
|
2003-08-28 |
2007-11-29 |
Biorexis Technology, Inc. |
Epo Mimetic Peptides and Fusion Proteins
|
JP4767857B2
(ja)
|
2003-09-30 |
2011-09-07 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ベンゾイミダゾール化合物
|
UA89481C2
(uk)
|
2003-09-30 |
2010-02-10 |
Центокор, Инк. |
Еритропоетинові міметичні шарнірно-серцевинні міметитіла людини, композиції, способи та застосування
|
UA93653C2
(ru)
|
2003-11-07 |
2011-03-10 |
Иммунекс Корпорейшн |
Выделенное антитело, kotopoe специфически связывается c человеческим рецептором il-4 (il-4r)
|
AR046639A1
(es)
|
2003-11-21 |
2005-12-14 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti- igfr1
|
US7405198B2
(en)
|
2003-11-24 |
2008-07-29 |
Neose Technologies, Inc. |
Glycopegylated erythropoietin
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
WO2005058967A2
(en)
|
2003-12-16 |
2005-06-30 |
Pierre Fabre Medicament |
Novel anti-insulin/igf-i hybrid receptor or anti-insulin/igf-i hybrid receptor and igf-ir antibodies and uses thereof
|
EP1548031A1
(en)
|
2003-12-22 |
2005-06-29 |
Dubai Genetics FZ-LLC |
Nature-identical erythropoietin
|
CN1902222A
(zh)
|
2003-12-31 |
2007-01-24 |
默克专利有限公司 |
具有改善药物代谢动力学的Fc-促红细胞生成素融合蛋白质
|
JP2008500275A
(ja)
|
2003-12-31 |
2008-01-10 |
セントカー・インコーポレーテツド |
N末端の遊離チオールを有する新規な組み換えタンパク質
|
US7423139B2
(en)
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
WO2005070451A1
(en)
|
2004-01-22 |
2005-08-04 |
Zafena Aktiebolag |
Pharmaceutical composition comprising non-glycosylated erythropoietin
|
WO2005084711A1
(fr)
|
2004-03-02 |
2005-09-15 |
Chengdu Institute Of Biological Products |
Erythropoietine recombinante pegylee a activite in vivo
|
TW200603818A
(en)
|
2004-03-11 |
2006-02-01 |
Fresenius Kabi De Gmbh |
Conjugates of hydroxyethyl starch and erythropoietin
|
ES2343810T3
(es)
*
|
2004-03-31 |
2010-08-10 |
Eli Lilly And Company |
Aparato de inyeccion que presenta una caja de agujas para administrar un liquido farmaceutico.
|
US20050227289A1
(en)
|
2004-04-09 |
2005-10-13 |
Reilly Edward B |
Antibodies to erythropoietin receptor and uses thereof
|
EP1737888A2
(en)
|
2004-04-23 |
2007-01-03 |
Cambridge Antibody Technology LTD |
Erythropoietin protein variants
|
DE602005014117D1
(de)
|
2004-07-07 |
2009-06-04 |
Lundbeck As Valby H |
Neues carbamyliertes epo und verfahren zu dessen herstellung
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
WO2006029094A2
(en)
|
2004-09-02 |
2006-03-16 |
Xencor, Inc. |
Erythropoietin derivatives with altered immunogenicity
|
WO2006050959A2
(en)
|
2004-11-10 |
2006-05-18 |
Aplagen Gmbh |
Molecules which promote hematopoiesis
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
US7906625B2
(en)
|
2005-01-24 |
2011-03-15 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
JP4001606B2
(ja)
|
2005-05-31 |
2007-10-31 |
パウダーテック株式会社 |
樹脂充填型キャリア及び該キャリアを用いた電子写真現像剤
|
ES2452115T3
(es)
|
2005-06-17 |
2014-03-31 |
Imclone Llc |
Un anticuerpo anti-PDGFRalfa para su uso en el tratamiento de cáncer de huesos metastásico
|
WO2007000328A1
(en)
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
|
EA021669B1
(ru)
|
2005-07-18 |
2015-08-31 |
Амджен Инк. |
Нейтрализующие антитела человека против b7rp1
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
MX2008014744A
(es)
|
2006-05-19 |
2009-02-10 |
Glycofi Inc |
Composiciones de eritrocpoyetina.
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
US7767206B2
(en)
|
2006-10-02 |
2010-08-03 |
Amgen Inc. |
Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto
|
WO2008140546A2
(en)
*
|
2006-10-16 |
2008-11-20 |
Alcon Research, Ltd. |
Limited reuse assembly for ophthalmic injection device
|
WO2008133647A2
(en)
|
2006-11-07 |
2008-11-06 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
CA2669424A1
(en)
|
2006-11-07 |
2008-05-29 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
CA2668131A1
(en)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
WO2008057458A2
(en)
|
2006-11-07 |
2008-05-15 |
Merck & Co., Inc. |
Antagonists of pcsk9
|
EA200901376A1
(ru)
|
2007-04-13 |
2010-12-30 |
Новартис Аг |
Молекулы и способы модуляции пропротеинконвертазы субтилизинового/кексинового типа 9(pcsk9)
|
JP2010535039A
(ja)
*
|
2007-08-01 |
2010-11-18 |
アルコン リサーチ, リミテッド |
使い捨て眼科用注射装置
|
EP2205639B1
(en)
|
2007-10-26 |
2015-12-23 |
Merck Sharp & Dohme Corp. |
Anti-pcsk9 and methods for treating lipid and cholesterol disorders
|
AR070315A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Anticuerpos 1b20 antagonistas de pcsk9
|
AR070316A1
(es)
|
2008-02-07 |
2010-03-31 |
Merck & Co Inc |
Antagonistas de pcsk9 (proproteina subtilisina-kexina tipo 9)
|
US9974904B2
(en)
|
2008-05-20 |
2018-05-22 |
Avant Medical Corp. |
Autoinjector system
|
US8052645B2
(en)
|
2008-07-23 |
2011-11-08 |
Avant Medical Corp. |
System and method for an injection using a syringe needle
|
US8177749B2
(en)
|
2008-05-20 |
2012-05-15 |
Avant Medical Corp. |
Cassette for a hidden injection needle
|
TWI516501B
(zh)
|
2008-09-12 |
2016-01-11 |
禮納特神經系統科學公司 |
Pcsk9拮抗劑類
|
JO3672B1
(ar)
|
2008-12-15 |
2020-08-27 |
Regeneron Pharma |
أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
|
US20120219558A1
(en)
|
2009-09-25 |
2012-08-30 |
Yan Ni |
Antagonists of pcsk9
|
EP2493507A4
(en)
|
2009-10-30 |
2013-11-20 |
Merck Sharp & Dohme |
ANTAGONISTS AND VARIANTS AX213 AND AX132 PCSK9
|
CA2777698A1
(en)
|
2009-10-30 |
2011-05-05 |
Merck Sharp & Dohme Corp. |
Ax1 and ax189 pcsk9 antagonists and variants
|
AR079336A1
(es)
|
2009-12-11 |
2012-01-18 |
Irm Llc |
Antagonistas de la pro-proteina convertasa-subtilisina/quexina tipo 9 (pcsk9)
|
US8858500B2
(en)
|
2009-12-30 |
2014-10-14 |
Medtronic Minimed, Inc. |
Engagement and sensing systems and methods
|
BR112012022917A2
(pt)
|
2010-03-11 |
2017-01-10 |
Pfizer |
anticorpos com ligação a antígeno dependente de ph
|
US8430849B2
(en)
*
|
2010-09-24 |
2013-04-30 |
Perqflo, Llc |
Infusion pumps and plunger pusher position-responsive cartridge lock for infusion pumps
|
WO2012054438A1
(en)
|
2010-10-22 |
2012-04-26 |
Schering Corporation |
Anti-pcsk9
|
EP2468339A1
(en)
*
|
2010-12-21 |
2012-06-27 |
Sanofi-Aventis Deutschland GmbH |
Auto-injector
|
EP2468340A1
(en)
*
|
2010-12-21 |
2012-06-27 |
Sanofi-Aventis Deutschland GmbH |
Auto injector with an interlock switch detecting the position of the needle shroud
|
AR084456A1
(es)
|
2010-12-22 |
2013-05-15 |
Genentech Inc |
Anticuerpo anti-pcsk9 y metodos de uso
|
EP2668212B1
(en)
|
2011-01-28 |
2018-03-21 |
Sanofi Biotechnology |
Human antibodies to pcsk9 for use in methods of treating particular groups of subjects
|
JP2014511378A
(ja)
|
2011-02-11 |
2014-05-15 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Pcsk9アンタゴニスト
|
CA3021845C
(en)
|
2011-04-20 |
2022-03-29 |
Amgen Inc. |
Autoinjector apparatus
|
JP6050331B2
(ja)
*
|
2011-05-25 |
2016-12-21 |
サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
投薬インターフェース・センサを有する薬剤送達デバイスおよびこのデバイスを制御する方法
|
CN105517594A
(zh)
*
|
2013-09-10 |
2016-04-20 |
赛诺菲-安万特德国有限公司 |
致动步骤故障处理
|